🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to demonstrate the superiority of combination of eprosartan/H...
Status
Completed
Location
Site 26
Start Date
2004-10
Trial ID
NCT00160160
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
PRACS Institute Ltd.
Start Date
2006-11
Trial ID
NCT01019590
The purpose of this study is to find out how chemicals in the blood of pati...
Status
Completed
Location
Clinical Reserach Center, UCSF
Start Date
2010-03
Trial ID
NCT01087749
Treatments Being Tested
The purpose of this study was to determine the bioavailability of benazepri...
Status
Completed
Location
aaiPharma, Inc
Start Date
2004-09
Trial ID
NCT00778726
Treatments Being Tested
In this open clinical trial, 30 subjects with inadequately controlled T2D a...
Status
Unknown
Location
University of Pisa
Start Date
2019-06-04
Trial ID
NCT04242758
Treatments Being Tested
The objective of this study was to compare the relative bioavailability of ...
Status
Completed
Location
Gateway Medical Research Inc
Start Date
2003-03
Trial ID
NCT00777972
Treatments Being Tested
In this study the effects of the Inhibition of the Sodium-Glucose Linked Tr...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2017-12-08
Trial ID
NCT03254849
Treatments Being Tested
To compare the changes in mean sitting DBP from baseline after 4 weeks of t...
Status
Completed
Location
Research Site
Start Date
2008-02
Trial ID
NCT00621153
Treatments Being Tested
The aim is to compare the blood pressure lowering effect of the combination...
Status
Completed
Location
Research Site
Start Date
2007-01
Trial ID
NCT00434967
Treatments Being Tested
The CandLE study with at maximum daily dose of 32 mg candesartan or 16/12.5...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00607633